Thermo Fisher Scientific (TMO) Current Assets (2009 - 2026)

Thermo Fisher Scientific has disclosed Current Assets across 18 years of filings, most recently posting $22.3 billion for Q1 2026.

• Quarterly Current Assets fell 4.54% year-over-year to $22.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.3 billion (down 4.54% YoY) and the FY2025 annual result came in at $28.7 billion, up 29.68% from the prior year.
• Current Assets slipped to $22.3 billion in Q1 2026, from $28.7 billion in the prior quarter.
• Over five years, Current Assets peaked at $28.7 billion in Q4 2025 and troughed at $18.1 billion in Q3 2022.
• A 5-year average of $22.7 billion and a median of $23.1 billion in 2023 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets retreated 21.94% — and 2025, when it advanced 29.68%.
• Tracing TMO's Current Assets over 5 years: stood at $25.2 billion in 2022, then dropped by 2.54% to $24.6 billion in 2023, then decreased by 9.97% to $22.1 billion in 2024, then gained by 29.68% to $28.7 billion in 2025, then slipped by 22.26% to $22.3 billion in 2026.
• Business Quant data shows TMO's Current Assets at $22.3 billion in Q1 2026, $28.7 billion in Q4 2025, and $22.3 billion in Q3 2025.